ARS Pharmaceuticals (SPRY) Payables (2020 - 2026)
ARS Pharmaceuticals' Payables came in at $59.73 million for Q2 2026, up 34.9% from $44.26 million a year earlier and up 23.8% from the prior quarter.
Powered by 
Analysis
ARS Pharmaceuticals (SPRY) Payables (2020 - 2026) Analysis & Trends
At the end of FY2025, ARS Pharmaceuticals' Payables was $37.95 million, up 66.1% from FY2024.
- Payables carries a five-year compound annual growth rate of 71.2% (FY2020 to FY2025).
- Going back by year, Payables was $22.84 million in FY2024 (+960.4%), $2.15 million in FY2023 (-56.3%), $4.93 million in FY2022 (-25.1%) and $6.59 million in FY2021 (+155.0%).
- The Q2 2026 figure represents the highest quarterly Payables in data going back to Q4 2020.
- Year-over-year, Payables has increased for eight consecutive quarters, with growth averaging 329.8% over the last eight quarters.
- The fastest year-over-year change in Payables over five years came in Q4 2024 (growth of 960.4%), and the weakest in Q3 2022 (a decline of 92.7%).
- Business Quant data shows SPRY's Payables at $48.26 million (Q1 2026), $37.95 million (Q4 2025) and $49.77 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 20.92 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 33.30 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 5.96 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 4.26 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -22.89 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 2.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 674.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 7.03 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 429.50 Mn |
| 10 | ARS Pharmaceuticals | 410.68 Mn | 266.88 Mn | 20.81 Mn | 59.73 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 59.73 Mn |
| Mar 31, 2026 | 48.26 Mn |
| Dec 31, 2025 | 37.95 Mn |
| Sep 30, 2025 | 49.77 Mn |
| Jun 30, 2025 | 44.26 Mn |
| Mar 31, 2025 | 27.01 Mn |
| Dec 31, 2024 | 22.84 Mn |
| Sep 30, 2024 | 16.52 Mn |
| Jun 30, 2024 | 6.57 Mn |
| Mar 31, 2024 | 3.50 Mn |
| Dec 31, 2023 | 2.15 Mn |
| Sep 30, 2023 | 10.95 Mn |
| Jun 30, 2023 | 9.82 Mn |
| Mar 31, 2023 | 9.60 Mn |
| Dec 31, 2022 | 4.93 Mn |
| Sep 30, 2022 | 126,000.00 |
| Jun 30, 2022 | 2.11 Mn |
| Mar 31, 2022 | 2.63 Mn |
| Dec 31, 2021 | 6.59 Mn |
| Sep 30, 2021 | 1.72 Mn |
API Access
ARS Pharmaceuticals Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=payables&ticker=SPRY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "payables", "ticker": "SPRY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=payables&ticker=SPRY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();